Integra LifeSciences Holdings 대차 대조표 상태
재무 상태 기준 확인 2/6
Integra LifeSciences Holdings 의 총 주주 지분은 $1.5B 이고 총 부채는 $1.8B, 이는 부채 대 자기자본 비율을 118.9% 로 가져옵니다. 총자산과 총부채는 각각 $4.1B 및 $2.5B 입니다. Integra LifeSciences Holdings 의 EBIT는 $193.9M 이며 이자보상배율은 4.2 입니다. $277.6M 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
118.9%
부채 비율
US$1.81b
부채
| 이자 보상 비율 | 4.2x |
| 현금 | US$277.60m |
| 주식 | US$1.52b |
| 총 부채 | US$2.54b |
| 총 자산 | US$4.07b |
최근 재무 상태 업데이트
Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21
We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Recent updates
There's No Escaping Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Muted Revenues Despite A 42% Share Price Rise
Nov 05Is Now The Time To Look At Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Oct 24Why Investors Shouldn't Be Surprised By Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Low P/S
Sep 08Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?
Jul 01Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
Jun 21Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price
May 28Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08재무 상태 분석
단기부채: IART 의 단기 자산 ( $1.1B )이 단기 부채( $912.6M ).
장기 부채: IART 의 단기 자산( $1.1B )은 장기 부채( $1.6B ).
부채 대 자본 내역 및 분석
부채 수준: IART 의 순부채 대 자기자본 비율( 100.6% )은 높음으로 간주됩니다.
부채 감소: IART 의 부채 대 자기자본 비율은 지난 5년간 107.3% 에서 118.9% 로 증가했습니다.
부채 범위: IART 의 부채는 영업 현금 흐름 ( 7.6% )에 의해 잘 갚지 않음입니다.
이자 보장: IART 의 부채에 대한 이자 지급은 EBIT( 4.2 x 적용 범위)로 잘 충당됩니다.